NASDAQ: CBLL
Ceribell Inc Stock

$26.14-0.21 (-0.8%)
Updated Nov 13, 2026
CBLL Price
$26.14
Fair Value Price
N/A
Market Cap
$1.02B
52 Week Low
$12.65
52 Week High
$28.89
P/E
-13.47x
P/B
8.64x
P/S
8.64x
PEG
N/A
Dividend Yield
N/A
Revenue
$108.72M
Earnings
-$73.88M
Gross Margin
89.3%
Operating Margin
-66.49%
Profit Margin
-68%
Debt to Equity
0.33
Operating Cash Flow
-$56M
Beta
1.45
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

CBLL Overview

CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine CBLL's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +5.11% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Medical Device

Industry Rating
B
CBLL
Ranked
#60 of 95

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$20.55A
$13.40A
$264.32A
View Top Medical Device Stocks

Be the first to know about important CBLL news, forecast changes, insider trades & much more!

CBLL News

Overview

Due Diligence Score

–
Industry Average (31)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CBLL scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CBLL is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CBLL is poor value based on its book value relative to its share price (8.64x), compared to the US Medical Devices industry average (3.33x)
P/B vs Industry Valuation
CBLL is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more CBLL due diligence checks available for Premium users.

Valuation

CBLL price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-13.47x
Industry
25.58x
Market
41.11x

CBLL price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
8.64x
Industry
3.33x
CBLL is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CBLL's financial health

Profit margin

Revenue
$29.3M
Net Income
-$21.4M
Profit Margin
-72.8%
CBLL's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
CBLL's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$156.4M
Liabilities
$38.8M
Debt to equity
0.33
CBLL's short-term assets ($147.44M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CBLL's short-term assets ($147.44M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CBLL's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$13.1M
Investing
$20.8M
Financing
$1.6M
CBLL's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

CBLL vs Medical Device Stocks

TickerZen RatingMarket Cap1d %P/EP/B
CBLLC$1.02B-0.80%-13.47x8.64x
AHCOC$1.05B-2.67%-2.57x0.85x
SIBNB$1.06B-2.90%-75.61x5.73x
IRMDC$1.09B+0.14%45.16x10.25x
ATECC$1.10B+0.14%-12.63x-476.47x

Ceribell Stock FAQ

What is Ceribell's quote symbol?

(NASDAQ: CBLL) Ceribell trades on the NASDAQ under the ticker symbol CBLL. Ceribell stock quotes can also be displayed as NASDAQ: CBLL.

If you're new to stock investing, here's how to buy Ceribell stock.

What is the 52 week high and low for Ceribell (NASDAQ: CBLL)?

(NASDAQ: CBLL) Ceribell's 52-week high was $28.89, and its 52-week low was $12.65. It is currently -9.52% from its 52-week high and 106.64% from its 52-week low.

How much is Ceribell stock worth today?

(NASDAQ: CBLL) Ceribell currently has 38,835,010 outstanding shares. With Ceribell stock trading at $26.14 per share, the total value of Ceribell stock (market capitalization) is $1.02B.

Ceribell stock was originally listed at a price of $25.00 in Oct 11, 2024. If you had invested in Ceribell stock at $25.00, your return over the last 2 years would have been 4.56%, for an annualized return of 2.25% (not including any dividends or dividend reinvestments).

How much is Ceribell's stock price per share?

(NASDAQ: CBLL) Ceribell stock price per share is $26.14 today (as of Nov 13, 2026).

What is Ceribell's Market Cap?

(NASDAQ: CBLL) Ceribell's market cap is $1.02B, as of Nov 16, 2026.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Ceribell's market cap is calculated by multiplying CBLL's current stock price of $26.14 by CBLL's total outstanding shares of 38,835,010.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.